The top five tweets: From MS to AMR — what did EPM readers click on this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.
5. Coming in fifth is the news that cladribine tablets will now be available for certain Scottish patients with MS.
4. Lonza’s announcement that it is establishing cell and gene therapy centres of excellence is in fourth place for the week.
3. Making into third place is NICE’s recommendation for tivoza to be a first-line treatment for kidney cancer.
2. Ferring Pharmaceuticals' investment into a new biotech centre is our runner up.
1. Topping the list this week is the news from the Open Data Institute about the pilot project it is delivering to improve data transparency on antimicrobial resistance.